As of 2025-04-29, the Fair Value of Design Therapeutics Inc (DSGN) is -4.37 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.06 USD, the upside of Design Therapeutics Inc is -207.59%.
With the market price of 4.06 USD and our fair value calculation, Design Therapeutics Inc (DSGN) is not a good investment. Investing in DSGN stocks now will result in a potential loss of 207.59%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -8.28 | -35.53 | -63.31 | -66.86 | -43.50 | |
| YoY growth | -303.90% | -329.11% | -78.19% | -5.61% | -179.20% | |
| Market Cap (mil) | 230.45 |
| P/E | |
| Forward P/E |
| EPS | -0.87 |
| Avg earnings growth rate | -179.20% |
| TTM earnings | -49.59 |